Fonte: Journal of Oral Pathology & Medicine. Unidade: FO
Assuntos: QUIMIOTERAPIA, CARCINOMA DE CÉLULAS ESCAMOSAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
PONTES, Flavia Sirotheau Corrêa et al. Effect of 17-allylamino-17-demethoxygeldanamycin (17-AAG) on Akt protein expression is more effective in head and neck cancer cell lineages that retain PTEN protein expression. Journal of Oral Pathology & Medicine, v. 47, n. 3, p. 253-259, 2018Tradução . . Disponível em: https://doi.org/10.1111/jop.12676. Acesso em: 05 nov. 2024.APA
Pontes, F. S. C., Pontes, H. A. R., Souza, L. L. de, Jesus, A. S. de, Joaquim, A. M. C., Miyahara, L. A. N., et al. (2018). Effect of 17-allylamino-17-demethoxygeldanamycin (17-AAG) on Akt protein expression is more effective in head and neck cancer cell lineages that retain PTEN protein expression. Journal of Oral Pathology & Medicine, 47( 3), 253-259. doi:10.1111/jop.12676NLM
Pontes FSC, Pontes HAR, Souza LL de, Jesus AS de, Joaquim AMC, Miyahara LAN, Fonseca FP, Pinto Júnior D dos S. Effect of 17-allylamino-17-demethoxygeldanamycin (17-AAG) on Akt protein expression is more effective in head and neck cancer cell lineages that retain PTEN protein expression [Internet]. Journal of Oral Pathology & Medicine. 2018 ; 47( 3): 253-259.[citado 2024 nov. 05 ] Available from: https://doi.org/10.1111/jop.12676Vancouver
Pontes FSC, Pontes HAR, Souza LL de, Jesus AS de, Joaquim AMC, Miyahara LAN, Fonseca FP, Pinto Júnior D dos S. Effect of 17-allylamino-17-demethoxygeldanamycin (17-AAG) on Akt protein expression is more effective in head and neck cancer cell lineages that retain PTEN protein expression [Internet]. Journal of Oral Pathology & Medicine. 2018 ; 47( 3): 253-259.[citado 2024 nov. 05 ] Available from: https://doi.org/10.1111/jop.12676
